CN Stock MarketDetailed Quotes

Shanghai Shenqi Pharmaceutical Investment Management (900904)

Watchlist
  • 0.512
  • +0.002+0.39%
Market Closed Jan 23 15:00 CST
273.44MMarket Cap32.00P/E (TTM)

Shanghai Shenqi Pharmaceutical Investment Management (900904) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
Total operating revenue
-10.58%1.4B
-13.47%960.85M
-16.47%479.93M
-12.48%2.05B
-8.61%1.56B
-7.91%1.11B
-1.42%574.53M
-2.00%2.34B
-0.13%1.71B
0.29%1.21B
Operating revenue
-10.58%1.4B
-13.47%960.85M
-16.47%479.93M
-12.48%2.05B
-8.61%1.56B
-7.91%1.11B
-1.42%574.53M
-2.00%2.34B
-0.13%1.71B
0.29%1.21B
Other operating revenue
----
-85.37%536.46K
----
-24.47%511.57K
----
44.59%3.67M
----
212.18%677.34K
----
-47.51%2.54M
Total operating cost
-11.03%1.32B
-14.19%903.53M
-16.15%455.83M
-12.57%1.92B
-8.97%1.48B
-8.33%1.05B
-1.35%543.62M
-4.69%2.2B
-0.06%1.63B
-0.72%1.15B
Operating cost
-7.40%740.08M
-12.57%510.77M
-12.50%255.47M
-8.28%1.08B
-3.13%799.21M
2.76%584.2M
8.18%291.96M
4.19%1.17B
8.49%825.03M
1.68%568.51M
Operating tax surcharges
2.30%22.41M
-1.69%14.47M
-7.47%9.24M
-7.42%26.91M
-3.63%21.91M
-10.73%14.72M
-5.25%9.99M
-1.93%29.07M
-5.02%22.73M
14.06%16.49M
Operating expense
-17.41%462.2M
-17.93%317.99M
-24.63%160.13M
-19.92%692.35M
-17.40%559.65M
-21.76%387.48M
-6.80%212.44M
-13.78%864.57M
-7.62%677.56M
-4.03%495.26M
Administration expense
4.89%69.82M
9.54%44.99M
17.70%21.91M
0.13%92.65M
6.99%66.57M
-0.04%41.08M
-6.28%18.62M
-1.80%92.53M
-3.28%62.22M
-4.09%41.1M
Financial expense
-20.91%1.49M
391.70%1.44M
-13.84%1.42M
-55.41%4.87M
-76.44%1.88M
-95.13%292.63K
-54.74%1.65M
-10.96%10.92M
-13.11%7.99M
-8.17%6.01M
-Interest expense (Financial expense)
-20.46%6.97M
-9.69%5.1M
-17.63%2.48M
-13.33%12.8M
-19.58%8.77M
-26.78%5.65M
-40.85%3.02M
-14.98%14.76M
-14.14%10.9M
-14.41%7.72M
-Interest Income (Financial expense)
8.32%-6.35M
36.29%-4.1M
20.36%-1.16M
-86.00%-9.6M
-91.18%-6.93M
-171.79%-6.43M
-14.37%-1.46M
19.48%-5.16M
17.11%-3.62M
22.96%-2.37M
Research and development
-31.77%21.76M
-44.85%13.85M
-14.55%7.66M
1.80%32.89M
1.29%31.9M
18.14%25.12M
-53.24%8.96M
-29.76%32.3M
-13.82%31.49M
18.14%21.26M
Credit Impairment Loss
46.41%-6.12M
48.02%-5.97M
-4,427.34%-3.91M
-656.39%-15.84M
-160.61%-11.42M
-159.09%-11.48M
--90.36K
217.71%2.85M
-256.40%-4.38M
-1,493.15%-4.43M
Asset Impairment Loss
-1,208.09%-12.6M
-506.81%-8.02M
---558.12K
68.07%-23.12M
53.98%-963.5K
36.89%-1.32M
----
-361.85%-72.41M
69.97%-2.09M
-3,641.37%-2.09M
Other net revenue
-76.58%-13.84M
-16.88%-11.18M
-484.17%-3.22M
42.80%-32.4M
-1,798.04%-7.84M
-148.80%-9.57M
-16.12%837.76K
-335.98%-56.64M
104.87%461.62K
-236.36%-3.85M
Fair value change income
430.78%1.01M
235.23%151.13K
2,939.00%223.66K
-102.66%-23.91K
-153.57%-306.26K
74.83%45.08K
-112.53%-7.88K
--897.68K
--571.75K
--25.79K
Invest income
----
----
----
55.34%1.26M
--797.14K
----
----
-54.10%810.17K
----
----
-Including: Investment income associates
----
----
----
-48.54%178.6K
----
----
----
433.25%347.03K
----
----
Asset deal income
-81.03%30.3K
----
----
-144.42%-119.33K
401.30%159.66K
303.77%151.92K
2,940.58%151.92K
105.19%268.66K
100.62%31.85K
-825.49%-74.55K
Other revenue
-1.42%3.84M
-12.70%2.65M
70.09%1.03M
-50.26%5.45M
-38.53%3.89M
11.34%3.04M
-35.18%603.36K
28.60%10.95M
80.18%6.33M
-0.04%2.73M
Operating profit
-10.85%66.26M
-3.69%46.14M
-34.22%20.88M
10.66%91.67M
-11.50%74.32M
-9.96%47.9M
-3.06%31.75M
25.80%82.84M
11.39%83.98M
10.71%53.2M
Add:Non operating Income
-81.83%117.18K
-87.79%70.01K
-82.03%5.11K
-72.45%256.77K
-19.01%644.75K
-10.96%573.16K
-79.45%28.45K
-0.84%931.93K
-35.75%796.06K
99.51%643.73K
Less:Non operating expense
-55.78%1.22M
-34.99%752.92K
88.27%733.93K
1,096.71%4.35M
324.41%2.76M
561.06%1.16M
3,209.69%389.84K
-89.81%363.16K
21.36%649.33K
-64.68%175.19K
Total profit
-9.77%65.16M
-3.94%45.45M
-35.79%20.15M
5.00%87.58M
-14.16%72.21M
-11.84%47.32M
-4.53%31.38M
31.92%83.41M
10.55%84.12M
12.09%53.67M
Less:Income tax cost
5.00%14.07M
31.01%11.04M
-29.16%4.44M
-14.51%21.5M
-28.25%13.4M
-56.03%8.43M
-34.24%6.26M
68.40%25.15M
-2.54%18.67M
26.74%19.16M
Net profit
-13.13%51.09M
-11.51%34.41M
-37.44%15.72M
13.42%66.08M
-10.14%58.81M
12.70%38.89M
7.59%25.12M
20.63%58.26M
14.96%65.45M
5.33%34.51M
Net profit from continuing operation
-13.13%51.09M
-11.51%34.41M
-37.44%15.72M
13.42%66.08M
-10.14%58.81M
12.70%38.89M
7.59%25.12M
20.63%58.26M
14.96%65.45M
5.33%34.51M
Less:Minority Profit
246.29%789.41K
52.41%1.61M
-38.64%723.08K
-521.92%-5.31M
-8.20%-539.63K
564.11%1.05M
367.98%1.18M
595.39%1.26M
-133.53%-498.72K
-128.77%-227.1K
Net profit of parent company owners
-15.25%50.3M
-13.29%32.81M
-37.38%14.99M
25.24%71.39M
-10.00%59.35M
8.93%37.84M
0.65%23.94M
17.41%57M
18.94%65.95M
8.64%34.74M
Earning per share
Basic earning per share
-18.18%0.09
-14.29%0.06
-25.00%0.03
18.18%0.13
-8.33%0.11
16.67%0.07
0.00%0.04
22.22%0.11
20.00%0.12
0.00%0.06
Diluted earning per share
-18.18%0.09
-14.29%0.06
-25.00%0.03
18.18%0.13
-8.33%0.11
16.67%0.07
0.00%0.04
22.22%0.11
20.00%0.12
0.00%0.06
Other composite income
-101.67%-223.22K
-157.97%-3.42M
-2,053.58%-4.37M
100.89%9.67M
263.89%13.35M
-119.81%-1.32M
-88.74%223.7K
140.59%4.81M
127.98%3.67M
177.52%6.69M
Other composite income of parent company owners
-101.67%-223.22K
-157.97%-3.42M
-2,053.58%-4.37M
100.89%9.67M
263.89%13.35M
-119.81%-1.32M
-88.74%223.7K
140.59%4.81M
127.98%3.67M
177.52%6.69M
Total composite income
-29.51%50.87M
-17.49%31M
-55.23%11.35M
20.10%75.75M
4.41%72.17M
-8.81%37.57M
0.03%25.35M
73.12%63.07M
57.74%69.12M
70.70%41.2M
Total composite income of parent company owners
-31.12%50.08M
-19.51%29.39M
-56.04%10.62M
31.13%81.06M
4.44%72.71M
-11.86%36.51M
-6.24%24.17M
68.49%61.81M
64.45%69.62M
77.45%41.42M
Total composite income of minority owners
246.29%789.41K
52.41%1.61M
-38.64%723.08K
-521.92%-5.31M
-8.20%-539.63K
564.11%1.05M
367.98%1.18M
595.39%1.26M
-133.53%-498.72K
-128.77%-227.1K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023
Total operating revenue -10.58%1.4B-13.47%960.85M-16.47%479.93M-12.48%2.05B-8.61%1.56B-7.91%1.11B-1.42%574.53M-2.00%2.34B-0.13%1.71B0.29%1.21B
Operating revenue -10.58%1.4B-13.47%960.85M-16.47%479.93M-12.48%2.05B-8.61%1.56B-7.91%1.11B-1.42%574.53M-2.00%2.34B-0.13%1.71B0.29%1.21B
Other operating revenue -----85.37%536.46K-----24.47%511.57K----44.59%3.67M----212.18%677.34K-----47.51%2.54M
Total operating cost -11.03%1.32B-14.19%903.53M-16.15%455.83M-12.57%1.92B-8.97%1.48B-8.33%1.05B-1.35%543.62M-4.69%2.2B-0.06%1.63B-0.72%1.15B
Operating cost -7.40%740.08M-12.57%510.77M-12.50%255.47M-8.28%1.08B-3.13%799.21M2.76%584.2M8.18%291.96M4.19%1.17B8.49%825.03M1.68%568.51M
Operating tax surcharges 2.30%22.41M-1.69%14.47M-7.47%9.24M-7.42%26.91M-3.63%21.91M-10.73%14.72M-5.25%9.99M-1.93%29.07M-5.02%22.73M14.06%16.49M
Operating expense -17.41%462.2M-17.93%317.99M-24.63%160.13M-19.92%692.35M-17.40%559.65M-21.76%387.48M-6.80%212.44M-13.78%864.57M-7.62%677.56M-4.03%495.26M
Administration expense 4.89%69.82M9.54%44.99M17.70%21.91M0.13%92.65M6.99%66.57M-0.04%41.08M-6.28%18.62M-1.80%92.53M-3.28%62.22M-4.09%41.1M
Financial expense -20.91%1.49M391.70%1.44M-13.84%1.42M-55.41%4.87M-76.44%1.88M-95.13%292.63K-54.74%1.65M-10.96%10.92M-13.11%7.99M-8.17%6.01M
-Interest expense (Financial expense) -20.46%6.97M-9.69%5.1M-17.63%2.48M-13.33%12.8M-19.58%8.77M-26.78%5.65M-40.85%3.02M-14.98%14.76M-14.14%10.9M-14.41%7.72M
-Interest Income (Financial expense) 8.32%-6.35M36.29%-4.1M20.36%-1.16M-86.00%-9.6M-91.18%-6.93M-171.79%-6.43M-14.37%-1.46M19.48%-5.16M17.11%-3.62M22.96%-2.37M
Research and development -31.77%21.76M-44.85%13.85M-14.55%7.66M1.80%32.89M1.29%31.9M18.14%25.12M-53.24%8.96M-29.76%32.3M-13.82%31.49M18.14%21.26M
Credit Impairment Loss 46.41%-6.12M48.02%-5.97M-4,427.34%-3.91M-656.39%-15.84M-160.61%-11.42M-159.09%-11.48M--90.36K217.71%2.85M-256.40%-4.38M-1,493.15%-4.43M
Asset Impairment Loss -1,208.09%-12.6M-506.81%-8.02M---558.12K68.07%-23.12M53.98%-963.5K36.89%-1.32M-----361.85%-72.41M69.97%-2.09M-3,641.37%-2.09M
Other net revenue -76.58%-13.84M-16.88%-11.18M-484.17%-3.22M42.80%-32.4M-1,798.04%-7.84M-148.80%-9.57M-16.12%837.76K-335.98%-56.64M104.87%461.62K-236.36%-3.85M
Fair value change income 430.78%1.01M235.23%151.13K2,939.00%223.66K-102.66%-23.91K-153.57%-306.26K74.83%45.08K-112.53%-7.88K--897.68K--571.75K--25.79K
Invest income ------------55.34%1.26M--797.14K---------54.10%810.17K--------
-Including: Investment income associates -------------48.54%178.6K------------433.25%347.03K--------
Asset deal income -81.03%30.3K---------144.42%-119.33K401.30%159.66K303.77%151.92K2,940.58%151.92K105.19%268.66K100.62%31.85K-825.49%-74.55K
Other revenue -1.42%3.84M-12.70%2.65M70.09%1.03M-50.26%5.45M-38.53%3.89M11.34%3.04M-35.18%603.36K28.60%10.95M80.18%6.33M-0.04%2.73M
Operating profit -10.85%66.26M-3.69%46.14M-34.22%20.88M10.66%91.67M-11.50%74.32M-9.96%47.9M-3.06%31.75M25.80%82.84M11.39%83.98M10.71%53.2M
Add:Non operating Income -81.83%117.18K-87.79%70.01K-82.03%5.11K-72.45%256.77K-19.01%644.75K-10.96%573.16K-79.45%28.45K-0.84%931.93K-35.75%796.06K99.51%643.73K
Less:Non operating expense -55.78%1.22M-34.99%752.92K88.27%733.93K1,096.71%4.35M324.41%2.76M561.06%1.16M3,209.69%389.84K-89.81%363.16K21.36%649.33K-64.68%175.19K
Total profit -9.77%65.16M-3.94%45.45M-35.79%20.15M5.00%87.58M-14.16%72.21M-11.84%47.32M-4.53%31.38M31.92%83.41M10.55%84.12M12.09%53.67M
Less:Income tax cost 5.00%14.07M31.01%11.04M-29.16%4.44M-14.51%21.5M-28.25%13.4M-56.03%8.43M-34.24%6.26M68.40%25.15M-2.54%18.67M26.74%19.16M
Net profit -13.13%51.09M-11.51%34.41M-37.44%15.72M13.42%66.08M-10.14%58.81M12.70%38.89M7.59%25.12M20.63%58.26M14.96%65.45M5.33%34.51M
Net profit from continuing operation -13.13%51.09M-11.51%34.41M-37.44%15.72M13.42%66.08M-10.14%58.81M12.70%38.89M7.59%25.12M20.63%58.26M14.96%65.45M5.33%34.51M
Less:Minority Profit 246.29%789.41K52.41%1.61M-38.64%723.08K-521.92%-5.31M-8.20%-539.63K564.11%1.05M367.98%1.18M595.39%1.26M-133.53%-498.72K-128.77%-227.1K
Net profit of parent company owners -15.25%50.3M-13.29%32.81M-37.38%14.99M25.24%71.39M-10.00%59.35M8.93%37.84M0.65%23.94M17.41%57M18.94%65.95M8.64%34.74M
Earning per share
Basic earning per share -18.18%0.09-14.29%0.06-25.00%0.0318.18%0.13-8.33%0.1116.67%0.070.00%0.0422.22%0.1120.00%0.120.00%0.06
Diluted earning per share -18.18%0.09-14.29%0.06-25.00%0.0318.18%0.13-8.33%0.1116.67%0.070.00%0.0422.22%0.1120.00%0.120.00%0.06
Other composite income -101.67%-223.22K-157.97%-3.42M-2,053.58%-4.37M100.89%9.67M263.89%13.35M-119.81%-1.32M-88.74%223.7K140.59%4.81M127.98%3.67M177.52%6.69M
Other composite income of parent company owners -101.67%-223.22K-157.97%-3.42M-2,053.58%-4.37M100.89%9.67M263.89%13.35M-119.81%-1.32M-88.74%223.7K140.59%4.81M127.98%3.67M177.52%6.69M
Total composite income -29.51%50.87M-17.49%31M-55.23%11.35M20.10%75.75M4.41%72.17M-8.81%37.57M0.03%25.35M73.12%63.07M57.74%69.12M70.70%41.2M
Total composite income of parent company owners -31.12%50.08M-19.51%29.39M-56.04%10.62M31.13%81.06M4.44%72.71M-11.86%36.51M-6.24%24.17M68.49%61.81M64.45%69.62M77.45%41.42M
Total composite income of minority owners 246.29%789.41K52.41%1.61M-38.64%723.08K-521.92%-5.31M-8.20%-539.63K564.11%1.05M367.98%1.18M595.39%1.26M-133.53%-498.72K-128.77%-227.1K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
View More
Nancy Pelosi Portfolio
Tariff game between the US and Europe shakes the market! Will TACO happen again?
Amidst the global market turbulence triggered by the US-Europe dispute over Greenland, a single post by Trump instantly reversed market tren Show More